Search research articles
Contact Us
Filters
Showing results (121-130 of 149) with videos related to
Page
of 15
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 8, 2012
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer
Charles C Hsu, Christopher L Wolfgang, Daniel A Laheru, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 14, 2012
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning
Haoming Qiu, Aaron T Wild, Hao Wang, et al.
Human Pathology
|
October 6, 2009
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients
K Ranh Voong, Jon Davison, Timothy M Pawlik, et al.
Annals of Surgery
|
May 16, 2013
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram
Trevor A Ellison, Christopher L Wolfgang, Chanjuan Shi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 22, 2014
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors
Kevin C Soares, Agnieszka A Rucki, Annie A Wu, et al.
Science (New York, N.Y.)
|
January 22, 2011
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors
Yuchen Jiao, Chanjuan Shi, Barish H Edil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2013
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma
Joseph M Herman, Katherine Y Fan, Aaron T Wild, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
Roeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
Gastroenterology
|
November 13, 2019
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells
Mingyang Liu, Yuqing Zhang, Jingxuan Yang, et al.
American Journal of Clinical Oncology
|
December 20, 2013
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer
Farzana Faisal, Hua-Ling Tsai, Amanda Blackford, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 149) with videos related to
Sort By:
Page
of 15
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
February 8, 2012
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer
Charles C Hsu, Christopher L Wolfgang, Daniel A Laheru, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 14, 2012
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning
Haoming Qiu, Aaron T Wild, Hao Wang, et al.
Human Pathology
|
October 6, 2009
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients
K Ranh Voong, Jon Davison, Timothy M Pawlik, et al.
Annals of Surgery
|
May 16, 2013
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram
Trevor A Ellison, Christopher L Wolfgang, Chanjuan Shi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 22, 2014
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors
Kevin C Soares, Agnieszka A Rucki, Annie A Wu, et al.
Science (New York, N.Y.)
|
January 22, 2011
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors
Yuchen Jiao, Chanjuan Shi, Barish H Edil, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2013
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma
Joseph M Herman, Katherine Y Fan, Aaron T Wild, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
Roeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
Gastroenterology
|
November 13, 2019
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells
Mingyang Liu, Yuqing Zhang, Jingxuan Yang, et al.
American Journal of Clinical Oncology
|
December 20, 2013
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer
Farzana Faisal, Hua-Ling Tsai, Amanda Blackford, et al.
Page
of 15